cephalosporin c has been researched along with 7432 s in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (6.86) | 18.7374 |
1990's | 111 (63.43) | 18.2507 |
2000's | 46 (26.29) | 29.6817 |
2010's | 5 (2.86) | 24.3611 |
2020's | 1 (0.57) | 2.80 |
Authors | Studies |
---|---|
De Abate, CA; Dennington, ML; Perrotta, RJ; Ziering, RM | 1 |
Bale, MJ; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Washington, JA | 1 |
Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Toda, T; Uchino, J | 1 |
Kumari, P; Lim, J; Lin, CC; Pan, HT | 1 |
Chiesa, M; Debbia, EA; Pesce, A; Ricotta, N; Schito, GC | 1 |
Cleary, TG; Contrini, M; Devoto, S; Gómez, H; Liu, H; López, E; Murray, BE; Prado, D; Woloj, M | 1 |
Iseki, K; Miyazaki, K; Sugawara, M | 1 |
Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
Doyle, WJ; Pinero, BP; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
Ardite, M; Blumer, JL; Jacobs, RF; Kearns, GL; Reed, MD; Yogev, RD | 1 |
Aiken, S; Cassano, KB; Chirurgi, VA; Edelstein, H; Karp, R; Krumpe, P; McCabe, RE; Oster, SE | 1 |
Debbia, EA; Pesce, A; Schito, GC | 1 |
Affrime, MB; Awni, WM; Halstenson, CE; Keane, WF; Kelloway, JS; Lim, J; Lin, CC; Matzke, GR | 1 |
Chanal, M; Derlot, E; Kitzis, MD; Meyran, M; Reverdy, ME; Soussy, CJ | 1 |
Andrews, JM; Ashby, JP; Thornber, D; Wise, R | 1 |
Barry, AL; Jones, RN | 5 |
Meyran, M; Thabaut, A | 1 |
Gudipati, S; Midkiff, BR; Westblom, TU | 1 |
Horiba, M; Nagata, Y; Suzuki, K | 1 |
Bragman, SG; Casewell, MW | 1 |
Bachmann, K; Jauregui, L; Martin, M; Nunlee, M; Schwartz, J | 1 |
Doko, F | 1 |
Hashimoto, H; Yachiku, S; Yamaguchi, S | 1 |
Hasuike, M; Hayashi, I; Ishii, T; Onuma, K | 1 |
Ito, T; Kanayama, H; Motomiya, M; Nakai, Y; Oizumi, K; Saito, J; Sato, K; Watanabe, A; Yoshida, T | 1 |
Higashimoto, J; Iwao, N; Miyoshi, S; Mizutani, S; Nishimura, K; Shiota, K; Yoshimura, K | 1 |
Andrews, JM; Nye, K; O'Neill, P; Wise, R; Wostenholme, M | 1 |
Hirano, K; Muranushi, N; Oguma, T; Yamada, H; Yoshida, M; Yoshikawa, T | 2 |
Kitagawa, T; Matsuura, A; Nagayama, T | 1 |
Cleary, TG; LaRocco, M; Shawar, R | 1 |
Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Iida, M; Ishii, H; Kitagawa, K; Mizuno, A; Nakashima, M; Oguma, T; Takiguchi, Y; Uematsu, T; Yamamoto, S; Yoshida, T | 1 |
Hamashima, Y; Ishikura, K; Konoike, T; Kubota, T; Minami, K; Motokawa, K; Nakashimizu, H; Yoshida, T; Yoshioka, M | 1 |
Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M | 1 |
Balfour, JA; Wiseman, LR | 1 |
Goldfarb, J; Gooch, WM; Mclinn, SE; Pichichero, ME; Reidenberg, BE; Rodriguez, W | 1 |
Mccarty, JM; Mclinn, SE; Perrotta, R; Pichichero, ME; Reidenberg, BE | 1 |
Blumer, JL; Deabate, CA; Kafetzis, DA; Mclinn, SE; Perrotta, RJ; Salgado, O | 1 |
Reidenberg, BE | 1 |
Jones, RN | 1 |
Chin, NX; Huang, HB; Neu, HC | 1 |
Neu, HC | 1 |
Affrime, M; Barr, WH; Batra, V; Lin, CC | 1 |
Iseki, K; Kobayashi, M; Miyazaki, K; Naasani, I; Sugawara, M | 1 |
Babálová, M; Blahová, J; Hupková, M; Králiková, K; Krcméry, V | 1 |
Iseki, K; Kobayashi, M; Miyazaki, K; Naasani, I; Sato, K; Sugawara, M | 1 |
Higashida, H; Nakayama, K; Takeuchi, T; Tamai, I; Tomizawa, N; Tsuji, A | 1 |
Affrime, M; Cayen, MN; Lin, C; Radwanski, E | 1 |
Affrime, M; Lim, J; Lin, C; Marco, A; Radwanski, E | 1 |
Iseki, K; Kobayashi, M; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Toda, T; Uchino, J | 1 |
Bressolle, F; Edno, L; Galtier, M; Gomeni, R; Goncalves, F; Kinowski, JM; Panis, R | 1 |
Hirano, K; Horie, K; Masuda, K; Muranushi, N | 1 |
Labia, R; Meyran, M; Morand, A; Sofer, L; Thabaut, A | 1 |
Drago, L; Fassina, C; Gismondo, MR; Lombardi, A | 1 |
Kim, H; Lim, JM; Lin, CC; Marco, A; Mojaverian, P | 1 |
Affrime, MB; Colucci, RD; Elliott, M; Zampaglione, N | 1 |
Edlund, C; Nord, CE; Stark, C | 1 |
Nicolau, DP; Nightingale, CH; Onyeji, CO; Quintiliani, R | 1 |
Bressolle, F; Fabre, D; Galtier, M; Goncalves, F; Kinowski, JM; Rouzier-Panis, R | 1 |
Inui, K; Matsumoto, S; Saito, H | 2 |
Nicoletti, G; Schito, GC | 1 |
Higashida, H; Kadowaki, A; Nakayama, K; Tamai, I; Terasaki, T; Tomizawa, N; Tsuji, A | 1 |
Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M; Takahashi, M; Toda, T | 1 |
Rodriguez, WJ; Wiedermann, BL | 1 |
Carret, G; Flandrois, JP; Guérillot, F | 1 |
Kearns, GL; Young, RA | 1 |
Iseki, K; Miyazaki, K; Satoh, Y; Sugawara, M | 1 |
Kumazawa, J | 1 |
Braga, PC; Piatti, G | 1 |
Hori, S; Nishikawa, T; Oguma, T; Shimada, J; Yamada, H; Yamamoto, S; Yoshikawa, T | 1 |
de Silva, JA; Kumari, P; Lin, CC; Pan, HT | 1 |
Doyle, WJ; Greene, I; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
McCabe, R; Mogabgab, W; Perrotta, R; Rumans, L | 1 |
Kumano, K; Kuroyama, M; Motohashi, S; Murase, S; Tomonaga, F | 1 |
Blandino, G; Nicoletti, G; Speciale, A | 1 |
Bluestone, CD; Casselbrant, ML; Kurs-Lasky, M; Mandel, EM | 1 |
Kumari, P; Lin, C; Perrotta, RJ; Reidenberg, BE | 1 |
Cellesi, C; Chigiotti, S; Corbisiero, R; Mencarelli, M; Rossolini, GM; Zanchi, A | 1 |
Iseki, K; Kikuchi, T; Kobayashi, M; Miyazaki, K; Naasani, I; Sugawara, M | 1 |
Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
Inui, KI; Mukai, M; Saito, H; Terada, T | 1 |
Akalin, E; Amann, S; Anğ, O; Bal, C; Bauernfeind, A; Casellas, JM; Jungwirth, R; Mangold, P; Stemplinger, I | 1 |
Banas, B; Combe, C; Manns, MP; Schlöndorff, D; Zoller, WG | 1 |
Awata, S; Inuzuka, K; Kan, K; Kawai, N; Sakagami, H; Washida, H | 1 |
Allegra, L; Catena, E; Centanni, S; Pozzi, E | 1 |
Alarcón, T; Díaz de Rojas, F; Domingo, D; López-Brea, M; Sánchez, I | 1 |
Demartini, G; Dugnani, S; Pintucci, JP; Scaglione, F | 1 |
Crellin, J; Medeiros, AA | 1 |
Pichichero, ME | 1 |
Guay, DR | 1 |
Inui, K; Mukai, M; Saito, H; Terada, T | 1 |
Iseki, K; Kikuchi, T; Kobayashi, M; Kohri, N; Miyazaki, K; Naasani, I; Sugawara, M | 1 |
Golusiński, W; Kopeć, T; Kruk-Zagajewska, A; Leszczyńska, M; Obrebowska, Z; Szmeja, Z; Szyfter, W; Wierzbicka, M | 2 |
Iseki, K; Kikuchi, T; Kobayashi, M; Kohri, N; Miyazaki, K; Naasani, I; Sugawara, M; Yonemura, K | 1 |
Verbist, L; Verhaegen, J | 1 |
Budanov, SV | 1 |
Guest, N; Langan, CE | 1 |
Kawashima, S; Koga, K; Murakami, M | 3 |
Hashimoto, N; Hirano, K | 1 |
Boschi, G; Caramia, G; Chetrì, G; Cupido, G; De Santis, A; Longhi, R; Marchisio, P; Meloni, G; Passali, D; Principi, N; Reali, E; Sacher, B; Salpietro, DC | 1 |
Dvoretskiĭ, LI; Iakovlev, SV; Shakhova, TV; Suvorova, MP | 1 |
Chan, LY; Cheung, WM; Chong, LY; Leung, CS; Yu, CW | 1 |
Hayakawa, T; Iseki, K; Kobayashi, M; Miyazaki, K; Naasani, I; Sato, K; Sugawara, M | 1 |
Affrime, M; Cutler, D; Lin, CC; Nomeir, A; Radwanski, E | 1 |
Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
Simon, MW | 1 |
Gould, IM; MacKenzie, FM; Milne, KE | 1 |
Affrime, MB; Cayen, MN; Krumpe, P; Lin, CC; Radwanski, E | 1 |
Ludwig, E; Székely, E | 1 |
Kawashima, S; Koga, K; Murakami, M; Ohyashiki, T | 1 |
Bhatnagar, S; Chandra, J | 1 |
Bhatia, SS; Dubey, AK; Sharma, RK; Vidyashankar, C | 1 |
Eampokalap, B; Moolasart, P; Ratanasrithong, M | 1 |
Larsson, P; Roos, K | 1 |
Badrinath, S; Deodhar, L; Kapoor, H; Menon, SS; Sengupta, S | 1 |
Bellussi, L; Boccazzi, A; Careddu, P; De'Angelis, M; Passali, D; Tonelli, P | 1 |
Amicosante, G; Bianchi, B; Caravelli, B; del Tavio-Perez, MM; Franceschini, N; Gizzi, G; Mancinelli, A; Perilli, M; Segatore, B; Setacci, D | 1 |
Docheva, Iu; Ergova, R; K'oleian, E; Kharalambieva, Ia; Mitov, I | 1 |
Ivanov, S; Markov, D; Mazneikova, V | 1 |
Adam, D; Helmerking, M; Scholz, H | 2 |
Banke, S; Bergman, B; Boman, H; Cronberg, S; Eilard, T; Elbel, E; Hugo-Persson, M; Johansson, E; Kuylenstierna, N; Lanbeck, P; Lindblom, A; Paulsen, O; Schönbeck, C; Walder, M; Wieslander, P | 1 |
Kleinkauf, N; Rodloff, AC | 1 |
Kardas, P; Ratajczyk-Pakalska, E | 1 |
Chaiwatanarat, T; Vilaichone, A; Watana, D | 1 |
Fung, CP; Ho, MW; Liu, CY; Wang, FD | 1 |
Kamanin, EI; Kozlov, SN; Otvagin, IV; Strachunskiĭ, LS | 1 |
Pŭnevska, M | 1 |
Hassan, KM; Murthy, D | 1 |
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
Ninkova, E; Stambolov, B; Vasilev, Kh | 1 |
Barr, WH; Menon, RM | 2 |
Lazarov, L; Lazarov, N; Lazarova, G | 1 |
Inui, K; Okuda, M; Pan, X; Terada, T | 1 |
Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
Inui, K; Katsura, T; Okamura, M; Saito, H; Terada, T | 1 |
Ahel, V; Averchenkova, L; Palcevski, G; Ratchina, S; Rosovic-Bazijanac, V; Vlahović-Palcevski, V | 1 |
Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Kubo, S; Otsuka, Y; Saito, Y; Yamamoto, Y | 1 |
Inui, K; Irie, M; Okuda, M; Terada, T | 1 |
Inui, K; Ji, L; Masuda, S; Nishihara, K; Okuda, M; Shimizu, Y | 1 |
Inui, K; Irie, M; Katsura, T; Matsuoka, S; Terada, T | 1 |
Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Saito, Y | 1 |
Atanasković-Marković, M; Cirković Velicković, T; Gavrović-Jankulović, M; Ivanovski, P; Nestorović, B | 1 |
Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Kubo, S; Saito, Y | 1 |
Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
Ferraro, SM; Giacomelli, L; Marchese-Ragona, R; Marioni, G; Ottaviano, G; Rinaldi, R; Staffieri, A; Staffieri, C | 1 |
Amicosante, G; Celenza, G; De Santis, F; Pellegrini, C; Perilli, M; Rossolini, GM; Segatore, B; Setacci, D; Tavio, M | 1 |
Cagnacci, S; Cassanelli, C; Cavallini, F; Debbia, EA; Gualco, L; Maioli, E; Marchese, A; Roveta, S | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Knütter, I; Neubert, K; Thondorf, I | 1 |
Berger, C; Bischoff, G; Buechner, K; Gervaix, A; Girardin, E; Goetschel, P; Hunziker, U; Husarik, D; Molinari, L; Nadal, D; Neuhaus, TJ; Parvex, P; Rudin, C; Stocker, S; Willi, U | 1 |
Ho, KM; Leung, AO; Lo, AC; Lo, JY; Tapsall, JW; Tiu, FS; Tsang, GK | 1 |
Jodal, U; Mårild, S; Sandberg, T | 1 |
Inui, K; Katsura, T; Okamura, M; Terada, T | 1 |
Arakawa, Y; Kimura, K; Kurokawa, H; Shibata, N; Suzuki, S; Wachino, J; Yamane, K | 1 |
Chuvilkin, VI; Chuvilkina, EI; Shirokov, IuE; Tsarev, VN | 1 |
Demirel, I; Kruse, R; Önnberg, A; Persson, K | 1 |
Akhmedov, GD; Chuvilkin, VI; Chuvilkina, EI; Gadzhiev, FN; Nikitin, IV; Tsarev, VN | 1 |
Arakawa, Y; Banno, H; Doyama, Y; Jin, W; Kamiya, C; Kimura, K; Miyazaki, A; Morimoto, M; Nagano, N; Wachino, J; Yamada, K | 1 |
Ahmad Murad, K; Chen, YT; Ng, LS; Park, JJ; Seah, JT; Tan, TY | 1 |
Caruso, C; Gaeta, F; Quaratino, D; Romano, A; Valluzzi, RL; Zaffiro, A | 1 |
13 review(s) available for cephalosporin c and 7432 s
Article | Year |
---|---|
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
Topics: Adult; Aged; Ceftibuten; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Male; Middle Aged; Therapeutic Equivalency | 1994 |
Worldwide safety experience with ceftibuten pediatric suspension.
Topics: Adolescent; Bacterial Infections; Ceftibuten; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Infant; Male; Suspensions; Treatment Outcome | 1995 |
Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.
Topics: Bacteria; Bacterial Infections; Ceftibuten; Cephalosporins; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Structure-Activity Relationship | 1995 |
Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
Topics: Bacteria; Bacterial Infections; beta-Lactamases; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1995 |
Pharmacokinetics of ceftibuten in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Bacterial Infections; Biological Availability; Ceftibuten; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Male; Suspensions | 1995 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
Topics: Adolescent; Adult; Aging; Animals; Bacteria; Biological Availability; Ceftibuten; Cephalosporins; Child; Child, Preschool; Drug Interactions; Humans; Infant; Intestinal Absorption; Microbial Sensitivity Tests; Otitis Media; Pediatrics; Respiratory Tract Infections; Tissue Distribution | 1994 |
[Ceftibuten].
Topics: Adult; Aged; Animals; Bacterial Infections; Ceftibuten; Cephalosporins; Female; Humans; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1993 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
Empiric antibiotic selection criteria for respiratory infections in pediatric practice.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ceftibuten; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy; Empiricism; Humans; Patient Compliance; Penicillin Resistance; Respiratory Tract Infections; Taste | 1997 |
Ceftibuten: a new expanded-spectrum oral cephalosporin.
Topics: Administration, Oral; Adult; Biological Availability; Ceftibuten; Cephalosporins; Clinical Trials as Topic; Humans; Intestinal Absorption; Microbial Sensitivity Tests | 1997 |
[Ceftibuten (Cedax)--a novel third generation oral cephalosporin in the treatment of bacterial infections].
Topics: Administration, Oral; Adult; Ceftibuten; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; Gram-Positive Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1998 |
Ceftibuten.
Topics: Ceftibuten; Cephalosporins; Enteritis; Humans; Pharmacokinetics; Respiratory Tract Infections; Urinary Tract Infections | 1999 |
38 trial(s) available for cephalosporin c and 7432 s
Article | Year |
---|---|
The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Single-Blind Method; Sinusitis | 1992 |
Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease.
Topics: Adolescent; Ceftibuten; Cephalosporins; Child; Child, Preschool; Dysentery, Bacillary; Escherichia coli Infections; Humans; Infant; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.
Topics: Adolescent; Aging; Ceftibuten; Cephalosporins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infant; Male | 1991 |
Ceftibuten versus cefaclor for the treatment of bronchitis.
Topics: Bacteria; Bronchitis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests | 1991 |
[In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study].
Topics: Acinetobacter; Administration, Oral; Bacteria, Anaerobic; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Haemophilus; In Vitro Techniques; Moraxella catarrhalis; Neisseria; Pseudomonas; Staphylococcus; Streptococcus | 1991 |
Failure of ceftibuten to alter single dose theophylline clearance.
Topics: Administration, Oral; Adult; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Interactions; Half-Life; Humans; Injections, Intravenous; Male; Random Allocation; Theophylline; Time Factors | 1990 |
Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Diet; Dose-Response Relationship, Drug; Drug Evaluation; Feces; Humans; Male; Protein Binding | 1988 |
Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
Topics: Adolescent; Ceftibuten; Cephalosporins; Child; Child, Preschool; Confidence Intervals; DNA, Bacterial; Double-Blind Method; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Prospective Studies; Scarlet Fever; Streptococcal Infections; Streptococcus pyogenes; Suspensions; Treatment Outcome | 1995 |
Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Members of the Ceftibuten Otitis Media United States Study Group.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ceftibuten; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media with Effusion; Patient Compliance; Treatment Outcome | 1995 |
Multinational multicenter controlled trial comparing ceftibuten with cefaclor for the treatment of acute otitis media. Members of the Ceftibuten Otitis Media International Study Group.
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media with Effusion; Prospective Studies; Single-Blind Method; Treatment Outcome | 1995 |
Multiple-dose pharmacokinetics of ceftibuten after oral administration to healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Capsules; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Half-Life; Humans; Male; Spectrophotometry, Ultraviolet; Stereoisomerism | 1994 |
Impact of ceftibuten on intestinal microflora: in vitro and in vivo studies.
Topics: Adult; Animals; Bacteria; Ceftibuten; Cephalosporins; Feces; Germ-Free Life; Humans; Intestines; Mice | 1994 |
Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children.
Topics: Amoxicillin; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Follow-Up Studies; Hearing Tests; Humans; Infant; Male; Otitis Media with Effusion; Penicillins; Recurrence | 1996 |
Penetration of ceftibuten into middle ear fluid.
Topics: Acute Disease; Ceftibuten; Cephalosporins; Child, Preschool; Chromatography, High Pressure Liquid; Ear, Middle; Humans; Infant; Otitis Media | 1996 |
[Effectiveness of and tolerance to ceftibuten in the treatment of chronic bacterial bronchitis exacerbations in an elderly population].
Topics: Aged; Bacterial Infections; Bronchitis; Ceftibuten; Cephalosporins; Chronic Disease; Female; Humans; Male; Middle Aged | 1996 |
[The evaluation of ceftibuten (Cedax) effectiveness in the prevention of perioperative infections].
Topics: Adult; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Male; Surgical Wound Infection | 1997 |
Comparison of the efficacy and safety of a short course of ceftibuten with that of amoxycillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Amoxicillin; Bronchitis; Ceftibuten; Cephalosporins; Chronic Disease; Clavulanic Acid; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Treatment Outcome | 1998 |
Epidemiology and treatment of otitis media with effusion in children in the first year of primary school.
Topics: Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Humans; Italy; Logistic Models; Male; Otitis Media with Effusion; Prevalence; Risk Factors; Time Factors; Treatment Outcome | 1998 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Community-Acquired Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Roxithromycin; Spiramycin | 1998 |
[Therapeutic effectiveness of Cedax in the treatment of selected acute upper respiratory diseases].
Topics: Acute Disease; Adolescent; Adult; Aged; Ceftibuten; Cephalosporins; Child; Child, Preschool; Humans; Middle Aged; Respiratory Tract Infections; Retrospective Studies | 1998 |
Clinical evaluation of ceftibuten in gonorrhea. A pilot study in Hong Kong.
Topics: Adolescent; Adult; Aged; Ceftibuten; Cephalosporins; Drug Resistance, Microbial; Gonorrhea; Hong Kong; Humans; Male; Middle Aged; Pilot Projects; Treatment Outcome; Urethritis | 1998 |
Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Biological Availability; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Ranitidine; Simethicone; Time Factors | 1998 |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors | 1999 |
Treatment of acute sinusitis in childhood with ceftibuten.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Erythromycin; Female; Humans; Infant; Male; Sinusitis; Sulfisoxazole | 1999 |
[Effectiveness of ceftibuten++ in the sequential therapy of respiratory and urinary tract infections].
Topics: Ceftibuten; Cephalosporins; Humans; Respiratory Tract Infections; Urinary Tract Infections | 1999 |
Ceftibuten in enteric fever.
Topics: Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Humans; Typhoid Fever | 2000 |
Comparison of the efficacy of ceftibuten and norfloxacin in the treatment of acute gastrointestinal infection in children.
Topics: Acute Disease; Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Diarrhea; Drug Resistance, Microbial; Dysentery, Bacillary; Female; Humans; Infant; Male; Norfloxacin; Prospective Studies; Salmonella Infections | 1999 |
Efficacy of ceftibuten in 5 versus 10 days treatment of recurrent acute otitis media in children.
Topics: Acute Disease; Ceftibuten; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Recurrence; Sweden; Treatment Outcome | 2000 |
Short course therapy with cefitbuten versus azithromycin in pediatric streptococcal pharyngitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2000 |
[Treatment of group A streptococcal tonsillopharyngitis. 5 days cephalosporin is as effective as 10 days penicillin].
Topics: Ceftibuten; Cephalosporins; Child; Drug Administration Schedule; Humans; Penicillin V; Pharyngitis; Prospective Studies; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2001 |
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftibuten; Cefuroxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norfloxacin; Prospective Studies; Pyelonephritis; Recurrence; Treatment Outcome | 2001 |
[Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Compliance; Respiratory Tract Infections | 2001 |
Oral ceftibuten switch therapy for acute pyelonephritis in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Ceftibuten; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Prospective Studies; Pyelonephritis; Reference Values; Treatment Outcome | 2001 |
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefixime; Ceftibuten; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2001 |
[Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis].
Topics: Adolescent; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Data Interpretation, Statistical; Follow-Up Studies; Humans; Infant; Penicillin V; Pharyngitis; Recurrence; Serotyping; Streptococcal Infections; Streptococcus pyogenes; Time Factors; Tonsillitis | 2001 |
Randomised trial of oral versus sequential intravenous/oral cephalosporins in children with pyelonephritis.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ceftibuten; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Pyelonephritis; Radionuclide Imaging; Technetium Tc 99m Dimercaptosuccinic Acid | 2008 |
Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children.
Topics: Anti-Infective Agents; Ceftibuten; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Male; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2009 |
[Preventive antibacterial treatment in oral bone augmentation procedures].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Ceftibuten; Cephalosporins; Dental Implantation; Female; Humans; Male; Prosthesis-Related Infections; Treatment Outcome | 2013 |
124 other study(ies) available for cephalosporin c and 7432 s
Article | Year |
---|---|
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
Topics: Anti-Bacterial Agents; Cefdinir; Cefpirome; Ceftibuten; Ceftizoxime; Cephalosporins; Clarithromycin; Erythromycin; Fleroxacin; Fluoroquinolones; Haemophilus; Humans; Microbial Sensitivity Tests; Quality Control; Quinolones; Spectinomycin; Virginiamycin | 1992 |
Transport characteristics of cephalosporin antibiotics across intestinal brush-border membrane in man, rat and rabbit.
Topics: Administration, Oral; Animals; Biological Transport; Ceftibuten; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Dipeptides; Humans; Intestinal Absorption; Microvilli; Rabbits; Rats; Species Specificity | 1992 |
Determination of a cephalosporin antibiotic, ceftibuten, in human plasma with column-switching high-performance liquid chromatography with ultraviolet detection.
Topics: Administration, Oral; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Lung Diseases; Methods | 1992 |
Microbiologic profile of ceftibuten, a new oral cephalosporin.
Topics: Bacteria; beta-Lactamases; Ceftibuten; Cephalosporins; Drug Interactions; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation | 1992 |
H+ coupled transport of orally active cephalosporins lacking an alpha-amino group across brush-border membrane vesicles from rat small intestine.
Topics: Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Hydrogen; In Vitro Techniques; Intestine, Small; Male; Membranes; Microvilli; Rats; Rats, Inbred Strains | 1991 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Drug Evaluation, Preclinical; Otitis Media with Effusion; Pneumococcal Infections | 1992 |
Antibacterial activity of ceftibuten, a new oral third generation cephalosporin.
Topics: beta-Lactamases; Ceftibuten; Cephalosporins; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 1991 |
Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
Topics: Adult; Aged; Biological Availability; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stereoisomerism | 1991 |
Ceftibuten--in-vitro activity against respiratory pathogens, beta-lactamase stability and mechanism of action.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cephalosporins; Drug Resistance, Microbial; Enzyme Stability; Haemophilus influenzae; Moraxella catarrhalis; Penicillin Resistance; Streptococcus pneumoniae | 1990 |
Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
Topics: Ceftibuten; Cephalosporins; Enterobacteriaceae; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Quality Control; Regression Analysis | 1990 |
[Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; In Vitro Techniques; Klebsiella pneumoniae | 1990 |
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Helicobacter pylori; Microbial Sensitivity Tests | 1990 |
[Clinical studies on ceftibuten in the urinary field infection].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Capsules; Ceftibuten; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Serratia marcescens; Urinary Tract Infections | 1990 |
The in-vitro activity of ceftibuten against 475 clinical isolates of gram-negative bacilli, compared with cefuroxime and cefadroxil.
Topics: Bacterial Infections; Cefadroxil; Ceftibuten; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1990 |
[Clinical studies of ceftibuten in the field of obstetrics and gynecology].
Topics: Administration, Oral; Adult; Capsules; Ceftibuten; Cephalosporins; Endometritis; Female; Genital Diseases, Female; Humans; Middle Aged; Pelvic Inflammatory Disease | 1990 |
[Clinical studies of ceftibuten in the field of urology].
Topics: Administration, Oral; Aged; Aged, 80 and over; Ceftibuten; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle Aged; Prostatitis; Urinary Tract Infections | 1990 |
[Clinical examination of ceftibuten in acute bronchitis].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Bronchitis; Ceftibuten; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle Aged | 1990 |
[Therapeutic efficacy of ceftibuten in chronic respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Capsules; Ceftibuten; Cephalosporins; Chronic Disease; Drug Evaluation; Eosinophilia; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1990 |
[Clinical experience with ceftibuten in complicated urinary tract infections].
Topics: Adult; Aged; Bacteria; Ceftibuten; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1990 |
Pharmacokinetics and tissue penetration of ceftibuten.
Topics: Adult; Biological Assay; Blister; Body Fluids; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Male; Stereoisomerism | 1990 |
Transport characteristics of ceftibuten (7432-S), a new oral cephem, in rat intestinal brush-border membrane vesicles: proton-coupled and stereoselective transport of ceftibuten.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Biological Transport, Active; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Ceftibuten; Cell Membrane; Cephalosporins; In Vitro Techniques; Intestine, Small; Male; Microvilli; Osmolar Concentration; Protons; Rats; Rats, Inbred Strains; Stereoisomerism | 1989 |
Analytical studies on beta-lactam antibiotics. III. Automated high-performance liquid chromatographic method for the determination of the orally active antibiotic ceftibuten in human plasma and urine.
Topics: Administration, Oral; Automation; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans | 1989 |
Transport characteristics of ceftibuten, a new oral cephem, in rat intestinal brush-border membrane vesicles: relationship to oligopeptide and amino beta-lactam transport.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Biological Transport, Active; Ceftibuten; Cell Membrane; Cephalosporins; Folic Acid; In Vitro Techniques; Intestine, Small; Male; Microvilli; Oligopeptides; Rats; Rats, Inbred Strains | 1989 |
Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.
Topics: Anti-Bacterial Agents; Campylobacter; Ceftibuten; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1989 |
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Carbapenems; Ceftibuten; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Respiratory Tract Infections | 1989 |
In-vitro antimicrobial activity of 7432-S (SCH39720) against commonly isolated respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1988 |
Ceftibuten (7432-S, SCH 39720): comparative antimicrobial activity against 4735 clinical isolates, beta-lactamase stability and broth microdilution quality control guidelines.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftibuten; Cephalosporins; Microbial Sensitivity Tests; Quality Control | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ceftibuten; Cephalosporins; Microbial Sensitivity Tests | 1988 |
Synthesis and biological properties of 7 beta-[(Z)-2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino]-3-cephem- 4-carboxylic acid (7432-S), a new oral cephem antibiotic.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactams; Biological Availability; Ceftibuten; Cephalosporins | 1987 |
Effect of membrane surface potential on the uptake of anionic compounds by liposomes.
Topics: Anions; Cefixime; Cefotaxime; Ceftibuten; Cell Membrane Permeability; Cephalosporins; Hydroxyindoleacetic Acid; Liposomes; Membrane Potentials; Phosphatidylserines | 1994 |
Postantibiotic effect of ceftibuten on respiratory pathogens.
Topics: Bacterial Infections; Ceftibuten; Cephalosporins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
Transport mechanism of ceftibuten, a dianionic cephem, in rat renal brush-border membrane.
Topics: Animals; Biological Transport; Ceftibuten; Cephalosporins; Hydrogen-Ion Concentration; Kidney; Male; Microvilli; Rats; Rats, Wistar; Substrate Specificity | 1995 |
Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
Topics: beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovakia | 1995 |
Comparison of the transport characteristics of ceftibuten in rat renal and intestinal brush-border membranes.
Topics: Animals; Biological Transport; Carnosine; Ceftibuten; Cephalosporins; Dipeptides; Dose-Response Relationship, Drug; Intestine, Small; Kidney Tubules, Proximal; Kinetics; Male; Microvilli; Rats; Rats, Wistar | 1995 |
Functional expression of transporter for beta-lactam antibiotics and dipeptides in Xenopus laevis oocytes injected with messenger RNA from human, rat and rabbit small intestines.
Topics: Animals; Biological Transport; Carrier Proteins; Cefadroxil; Ceftibuten; Cephalosporins; Humans; Hydrogen-Ion Concentration; Intestine, Small; Microinjections; Oocytes; Rabbits; Rats; RNA, Messenger; Xenopus laevis | 1995 |
Multiple-dose pharmacokinetics of ceftibuten in healthy volunteers.
Topics: Adult; Ceftibuten; Cephalosporins; Humans; Male | 1995 |
Pharmacokinetics and dose proportionality of ceftibuten in men.
Topics: Adult; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; Humans; Male | 1995 |
[Ceftibuten].
Topics: Ceftibuten; Cephalosporins | 1995 |
The inhibitory effects of cephalosporin and dipeptide on ceftibuten uptake by human and rat intestinal brush-border membrane vesicles.
Topics: Animals; Biological Transport, Active; Ceftibuten; Cephalosporins; Dipeptides; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Intestinal Mucosa; Intestines; Jejunum; Microvilli; Rats; Scintillation Counting | 1994 |
Characteristics of ceftibuten uptake into Caco-2 cells.
Topics: 2,4-Dinitrophenol; Administration, Oral; Amino Acids; Anti-Bacterial Agents; Ceftibuten; Cells, Cultured; Cephalosporins; Dinitrophenols; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Microvilli; Oligopeptides | 1994 |
Interactions of ceftibuten with extended-spectrum beta-lactamases: a bacteriological and enzymatic analysis.
Topics: beta-Lactamases; Ceftibuten; Cephalosporin Resistance; Cephalosporins; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1994 |
Liquid chromatographic determination of ceftibuten, a new oral cephalosporin, in human plasma and urine.
Topics: Administration, Oral; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Reproducibility of Results; Spectrophotometry, Ultraviolet; Stereoisomerism | 1994 |
Ceftibuten in paediatrics.
Topics: Ceftibuten; Cephalosporins; Child; Humans; Male; Otitis Media; Therapeutic Equivalency | 1994 |
The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances.
Topics: Administration, Oral; Adult; Amoxicillin; beta-Lactamases; Cefpodoxime Proxetil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Feces; Female; Humans; Intestines; Male; Middle Aged; Prodrugs | 1994 |
Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.
Topics: Abdomen; Animals; Bacterial Infections; Cefaclor; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Half-Life; Mice; Time Factors | 1994 |
High-performance liquid chromatographic determination of ceftibuten and its metabolite in biological fluids: applications in pharmacokinetic studies.
Topics: Administration, Oral; Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Drug Administration Schedule; Drug Stability; Humans; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Time Factors | 1994 |
Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.
Topics: Administration, Oral; Biological Transport; Ceftibuten; Cell Line; Cell Membrane; Cephalosporins; Cephradine; Dipeptides; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestines; Leucine | 1994 |
Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study Group.
Topics: Ceftibuten; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Humans; Italy; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus; Urinary Tract Infections | 1994 |
Functional expression of intestinal dipeptide/beta-lactam antibiotic transporter in Xenopus laevis oocytes.
Topics: Affinity Labels; Animals; Carrier Proteins; Ceftibuten; Cephalosporins; Cloning, Molecular; Dipeptides; Electrophoresis, Agar Gel; Hydrogen-Ion Concentration; Intestinal Mucosa; Oocytes; Protein Binding; Rats; RNA, Messenger; Temperature; Xenopus laevis | 1994 |
Changes in the permeation rate of organic anions through the intestinal brush-border membrane with membrane surface potential.
Topics: Anilino Naphthalenesulfonates; Animals; Anions; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Diffusion; Fluorescent Dyes; Hydrogen-Ion Concentration; Intestinal Mucosa; Membrane Potentials; Microvilli; Penicillin G; Permeability; Rats | 1994 |
A statistical evaluation of the bactericidal effects of ceftibuten in combination with aminoglycosides and ciprofloxacin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Statistics as Topic | 1993 |
[Effect of Enterued administration on the intestinal absorption of orally active cefem antibiotics].
Topics: Administration, Oral; Animals; Ceftibuten; Cephalexin; Cephalosporins; Drug Synergism; Enteral Nutrition; Humans; Intestinal Absorption; Intestine, Small; Male; Oligopeptides; Rats; Rats, Wistar | 1994 |
Sub-minimum inhibitory concentrations of ceftibuten reduce adherence of Escherichia coli to human cells and induces formation of long filaments.
Topics: Bacterial Adhesion; Ceftibuten; Cells, Cultured; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests; Mouth Mucosa | 1993 |
Effects of protein binding on the isomerization of ceftibuten.
Topics: Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Kinetics; Models, Biological; Protein Binding; Serum Albumin; Spectrophotometry, Ultraviolet; Stereoisomerism; Ultrafiltration | 1993 |
Determination of ceftibuten in sputum by column-switching high-performance liquid chromatography on-line with thermospray mass spectrometry.
Topics: Ceftibuten; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Male; Mass Spectrometry; Spectrophotometry, Ultraviolet; Sputum | 1993 |
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Random Allocation | 1993 |
Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Bronchiectasis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia | 1993 |
[Protein binding of oral cephems in patients with chronic renal failure].
Topics: Carrier Proteins; Cefdinir; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Humans; Kidney Failure, Chronic; Palmitic Acid; Palmitic Acids; Renal Dialysis | 1993 |
Transport characteristics of ceftibuten, a new cephaloporin antibiotic, via the apical H+/dipeptide cotransport system in human intestinal cell line Caco-2: regulation by cell growth.
Topics: Aminopeptidases; Caco-2 Cells; Cadherins; Carrier Proteins; Ceftibuten; Cell Division; Cephalosporins; Dipeptides; Humans; Hydrogen-Ion Concentration; Membrane Transport Proteins; Protons; Sodium-Potassium-Exchanging ATPase | 1995 |
Ceftibuten--a new oral cephalosporin.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; Ceftibuten; Cephalosporins; Controlled Clinical Trials as Topic; Diarrhea; Dose-Response Relationship, Drug; Humans; Intestinal Absorption | 1996 |
Third generation oral cephalosporins: comparative in vitro kinetics.
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalosporins; Escherichia coli; Haemophilus influenzae; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactam Resistance; Ceftibuten; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Penicillin G; Streptococcus pyogenes | 1996 |
Solubilization and reconstitution characteristics of the carrier protein(s) responsible for the transport of ceftibuten, a substrate for the oligopeptide transporters, in rat renal brush-border membrane.
Topics: Animals; Biological Transport; Carrier Proteins; Ceftibuten; Cephalosporins; Cholesterol; Glucosides; Hydrogen-Ion Concentration; Kidney; Liposomes; Male; Microvilli; Oligopeptides; Phosphatidylcholines; Phosphatidylserines; Phospholipids; Rats; Rats, Wistar; Solubility; Temperature | 1996 |
Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1.
Topics: Animals; Blotting, Western; Carrier Proteins; Ceftibuten; Cephalosporins; Cephradine; Diethyl Pyrocarbonate; Dipeptides; Histidine; Hydrogen-Ion Concentration; LLC-PK1 Cells; Microscopy, Fluorescence; Mutagenesis, Site-Directed; Oocytes; Peptide Transporter 1; Plasmids; Rats; Recombinant Proteins; Swine; Symporters; Transfection; Xenopus | 1996 |
Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Ceftibuten; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Genes, Bacterial; Genetic Vectors; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Salmonella typhimurium | 1996 |
[Antibiotic-induced prolonged cholestasis: suspected induction by ceftibuten].
Topics: Adult; Ceftibuten; Cephalosporin Resistance; Cephalosporins; Cholestasis, Intrahepatic; Fatal Outcome; Female; Humans; Liver; Otitis Externa; Pseudomonas Infections; Sepsis | 1996 |
[Morphological response of urinary bacteria to ceftibuten].
Topics: Ceftibuten; Cell Wall; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microscopy, Electron; Microscopy, Phase-Contrast; Urinary Tract Infections | 1996 |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Ceftibuten; Cephalosporins; Clarithromycin; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Penicillins; Stomach | 1996 |
Ceftibuten concentrations in human tonsillar tissue.
Topics: Adolescent; Adult; Ceftibuten; Cephalosporins; Half-Life; Humans; Male; Palatine Tonsil; Pharyngitis; Tonsillectomy; Tonsillitis | 1996 |
Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cephalosporins; Disease Outbreaks; Escherichia coli; Escherichia coli Infections; Hospitals; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nursing Homes | 1997 |
Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Ceftibuten; Cephalosporins; Cyclacillin; Dipeptides; Hydrogen-Ion Concentration; Kidney; Kinetics; LLC-PK1 Cells; Peptide Transporter 1; Rats; Recombinant Proteins; Structure-Activity Relationship; Symporters; Transfection | 1997 |
Purification and liposomal reconstitution of the oligopeptide transport activity in rat renal cortex using ceftibuten-affinity chromatography.
Topics: Animals; Biological Transport; Carrier Proteins; Ceftibuten; Cell Extracts; Cephalosporins; Chromatography, Affinity; Glucosides; Kidney Cortex; Male; Microvilli; Molecular Weight; Oligopeptides; Phosphatidylcholines; Phospholipids; Proteolipids; Rats; Rats, Wistar | 1998 |
Purification by ceftibuten-affinity chromatography and the functional reconstitution of oligopeptide transporter(s) in rat intestinal brush-border membrane.
Topics: Animals; Biological Transport; Carrier Proteins; Ceftibuten; Cephalosporins; Chromatography, Affinity; Electrophoresis, Polyacrylamide Gel; Intestinal Mucosa; Jejunum; Liposomes; Male; Membrane Proteins; Microvilli; Rats; Rats, Wistar; Solubility | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
Effects of fatty acid sucrose esters on ceftibuten transport by rat intestinal brush-border membrane vesicles.
Topics: Animals; Biological Transport; Ceftibuten; Cephalosporins; Esters; Fatty Acids; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestines; Intracellular Membranes; Membrane Lipids; Micelles; Microvilli; Rats; Solubility; Sucrose | 1998 |
Isomerization of ceftibuten in aqueous solution.
Topics: Ceftibuten; Cephalosporins; Hydrogen-Ion Concentration; Models, Chemical; Stereoisomerism; Temperature; Water | 1998 |
Modification of ceftibuten transport by changes in lipid fluidity caused by fatty acid glycerol esters.
Topics: Animals; Biological Transport; Ceftibuten; Cephalosporins; Fatty Acids; Glycerol; In Vitro Techniques; Intestine, Small; Membrane Lipids; Microvilli; Rats; Rats, Wistar; Surface-Active Agents | 1999 |
Multiplicity of the H+-dependent transport mechanism of dipeptide and anionic beta-lactam antibiotic ceftibuten in rat intestinal brush-border membrane.
Topics: Animals; Biological Transport, Active; Ceftibuten; Cephalosporins; Dipeptides; In Vitro Techniques; Intestinal Mucosa; Intestines; Kinetics; Male; Microvilli; Protons; Rats; Rats, Wistar | 1999 |
Effects of fatty acid glycerol esters on intestinal absorptive and secretory transport of ceftibuten.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Ceftibuten; Cephalosporins; Esters; Fatty Acids; Glycerol; Intestinal Absorption; Male; Rats; Rats, Wistar; Surface-Active Agents | 1999 |
The post-exposure response of Enterobacteriaceae to ceftibuten.
Topics: Ceftibuten; Cell Division; Cephalosporins; Enterobacteriaceae; Luminescent Measurements; Microbial Sensitivity Tests; Microbiological Techniques | 1999 |
The penetration of ceftibuten into the respiratory tract.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Bronchoscopy; Ceftibuten; Cephalosporins; Humans; Male; Middle Aged; Respiratory System; Respiratory Tract Diseases; Tissue Distribution | 1999 |
Modification of ceftibuten transport by the addition of non-ionic surfactants.
Topics: Animals; Ceftibuten; Cephalosporins; Intestine, Small; Male; Membrane Fluidity; Membrane Lipids; Membrane Proteins; Microvilli; Rats; Rats, Wistar; Surface-Active Agents | 2000 |
Spectrum of antibiogram against pathogens related to respiratory tract infections with a special reference to ceftibuten: a multicentric study.
Topics: Administration, Oral; Bacteria; Bacterial Infections; Ceftibuten; Cephalosporins; Humans; India; Microbial Sensitivity Tests; Respiratory Tract Infections | 2000 |
Ceftibuten stability to active-site serine and metallo-beta-lactamases.
Topics: beta-Lactamases; Binding Sites; Catalysis; Ceftibuten; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Hydrolysis; Serine | 2001 |
[A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
Topics: Ampicillin; beta-Lactamases; Ceftazidime; Ceftibuten; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sensitivity and Specificity | 2000 |
[Prophylaxis of postabortion endometriosis with Cedax].
Topics: Abortion, Induced; Adolescent; Adult; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Endometritis; Female; Gram-Negative Bacteria; Humans; Pregnancy; Pregnancy in Diabetics; Risk Factors; Ultrasonography | 2000 |
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN 58 940 method.
Topics: Bacteria; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Quality Control; Reference Values; Reproducibility of Results | 2001 |
[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis].
Topics: Acute Disease; Adult; Ceftibuten; Cefuroxime; Cephalosporins; Drug Tolerance; Female; Humans; Male; Sinusitis; Treatment Outcome | 2001 |
[Treatment with cedax in asymptomatic bacteriuria in the first trimester of pregnancy].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bacteriuria; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Urinary Tract Infections | 2001 |
[Therapeutic recommendation in acute suppurative sinusitis. Antibiotic plus topical steroid].
Topics: Administration, Topical; Bacterial Infections; Ceftibuten; Cephalosporins; Drug Therapy, Combination; Humans; Mometasone Furoate; Pregnadienediols; Sinusitis | 2001 |
The changing pattern of multi-drug resistant enteric fever--a physician's dilemma.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ceftibuten; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Quinolones; Time Factors; Typhoid Fever | 2001 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
[Treatment of obstetric and gynecologic diseases with anti-inflammatory drug cedax].
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Ceftibuten; Cephalosporins; Female; Genital Diseases, Female; Humans; Kidney Diseases; Middle Aged; Pregnancy; Pregnancy Complications | 2002 |
Transporters involved in apical and basolateral uptake of ceftibuten into Caco-2 cells.
Topics: Caco-2 Cells; Carrier Proteins; Ceftibuten; Cephalosporins; Humans; Membrane Transport Proteins; Peptide Transporter 1; Symporters | 2002 |
[Our experience with cedax (ceftibuten) in the obstetrical and gynecological practice].
Topics: Administration, Oral; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Ceftibuten; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pregnancy; Pregnancy Complications, Infectious | 2003 |
Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten.
Topics: Animals; Cadherins; Carrier Proteins; Ceftibuten; Cephalosporins; Circadian Rhythm; Fasting; Intestinal Absorption; Intestine, Small; Male; Membrane Transport Proteins; Peptide Transporter 1; Rats; Rats, Wistar; RNA, Messenger; Symporters | 2003 |
Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
Topics: Animals; Biological Transport; Caco-2 Cells; Ceftibuten; Cephalosporins; Diffusion Chambers, Culture; Humans; In Vitro Techniques; Jejunum; Male; Rats; Rats, Wistar | 2003 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Inhibitory effect of zinc on PEPT1-mediated transport of glycylsarcosine and beta-lactam antibiotics in human intestinal cell line Caco-2.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Caco-2 Cells; Carrier Proteins; Cefotiam; Ceftibuten; Cephalosporins; Cephradine; Dipeptides; Humans; In Vitro Techniques; Oocytes; Peptide Transporter 1; Rats; Symporters; Xenopus; Zinc | 2003 |
Antibiotic use profile at paediatric clinics in two transitional countries.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Ceftibuten; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Child, Preschool; Croatia; Data Collection; Developing Countries; Doxycycline; Drug Utilization Review; Gentamicins; Hospital Records; Hospitals, University; Humans; Infant; Leucomycins; Outpatient Clinics, Hospital; Pharmacoepidemiology; Retrospective Studies; Russia | 2004 |
H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine.
Topics: Animals; Biological Transport; Ceftibuten; Cephalosporins; Cyclohexanes; Dose-Response Relationship, Drug; Hypoglycemic Agents; Intestine, Small; Microvilli; Nateglinide; Phenylalanine; Protons; Rats | 2005 |
Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2.
Topics: Anti-Bacterial Agents; Biological Transport; Caco-2 Cells; Carbon Radioisotopes; Ceftibuten; Cell Polarity; Cephalosporins; Computer Simulation; Cyclacillin; Dipeptides; Humans; Hydrogen-Ion Concentration; Intestinal Mucosa; Kinetics; Linear Models; Membrane Transport Proteins; Models, Biological | 2004 |
[Treatment mostly not in line with current knowledge. New guidelines for sinusitis therapy].
Topics: Acute Disease; Bacterial Infections; Ceftibuten; Cephalosporins; Chronic Disease; Clavulanic Acid; Drug Resistance, Multiple; Humans; Mometasone Furoate; Penicillanic Acid; Pregnadienediols; Sinusitis; Treatment Outcome | 2004 |
Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats.
Topics: Animals; Blotting, Western; Ceftibuten; Cephalosporins; Dipeptides; Disease Progression; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Kidney; Male; Nephrectomy; Osmolar Concentration; Peptide Transporter 1; Rats; Rats, Wistar; Renal Insufficiency; RNA, Messenger; Symporters; Triiodothyronine | 2005 |
Computational modelling of H+-coupled peptide transport via human PEPT1.
Topics: Anions; Caco-2 Cells; Cations; Ceftibuten; Cephalosporins; Computer Simulation; Dipeptides; Electrochemistry; Humans; Hydrogen-Ion Concentration; Membrane Potentials; Models, Chemical; Peptide Transporter 1; Peptides; Protein Binding; Protons; Symporters | 2005 |
Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane.
Topics: Animals; Ceftibuten; Cephalosporins; Cyclohexanes; Ion Transport; Kidney; Male; Microvilli; Nateglinide; Peptide Transporter 1; Phenylalanine; Protons; Rats; Rats, Wistar; Symporters | 2005 |
A case of selective IgE-mediated hypersensitivity to ceftibuten.
Topics: Anaphylaxis; Ceftibuten; Cephalosporins; Child, Preschool; Communicable Diseases; Ear Diseases; Female; Humans; Immunoglobulin E; Skin Tests | 2005 |
Purification by p-aminobenzoic acid (PABA)-affinity chromatography and the functional reconstitution of the nateglinide/H+ cotransport system in the rat intestinal brush-border membrane.
Topics: 4-Aminobenzoic Acid; Animals; Benzoic Acid; Biological Transport; Ceftibuten; Cell Membrane; Cephalosporins; Chromatography, Affinity; Chromatography, High Pressure Liquid; Cyclohexanes; Dioxins; Dose-Response Relationship, Drug; Durapatite; Electrophoresis, Polyacrylamide Gel; Fluorescein; Hypoglycemic Agents; Intestinal Mucosa; Intestine, Small; Liposomes; Male; Microvilli; Nateglinide; Phenylalanine; Proteolipids; Protons; Rats; Rats, Wistar; Salicylic Acid; Ultraviolet Rays | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Burkholderia cepacia complex nasal isolation in immunocompetent patients with sinonasal polyposis not associated with cystic fibrosis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cefazolin; Ceftibuten; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nasal Polyps; Ofloxacin; Prospective Studies; Sinusitis; Sulbactam | 2007 |
In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ceftibuten; Cells, Cultured; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Mutation | 2007 |
In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens.
Topics: Anti-Bacterial Agents; Biofilms; Ceftibuten; Cell Physiological Phenomena; Cells, Cultured; Cephalosporins; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 2007 |
Recognition of 2-aminothiazole-4-acetic acid derivatives by the peptide transporters PEPT1 and PEPT2.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Biological Transport; Caco-2 Cells; Ceftibuten; Cells, Cultured; Cephalosporins; Dipeptides; Humans; Kidney Tubules, Proximal; Kinetics; Models, Molecular; Molecular Structure; Oligopeptides; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2007 |
Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection.
Topics: Anti-Bacterial Agents; Ceftibuten; Cephalosporin Resistance; Cephalosporins; Female; Genes, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Failure | 2008 |
Inhibitory effect of zinc on the absorption of beta-lactam antibiotic ceftibuten via the peptide transporters in rats.
Topics: Animals; beta-Lactams; Ceftibuten; Cephalosporins; Intestinal Absorption; Male; Membrane Transport Proteins; Peptide Transporter 1; Rats; Rats, Wistar; Symporters; Zinc | 2008 |
Practical disk diffusion test for detecting group B streptococcus with reduced penicillin susceptibility.
Topics: Anti-Bacterial Agents; Ceftibuten; Ceftizoxime; Cephalosporins; Disk Diffusion Antimicrobial Tests; Humans; Oxacillin; Penicillin Resistance; Penicillins; Sensitivity and Specificity; Streptococcal Infections; Streptococcus agalactiae | 2009 |
Ceftibuten-induced filamentation of extended spectrum beta lactamase (ESBL)-producing uropathogenic Escherichia coli alters host cell responses during an in vitro infection.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; beta-Lactamases; Ceftibuten; Cell Line; Cephalosporins; Escherichia coli Infections; Escherichia coli Proteins; Humans; Interleukin-6; Interleukin-8; Reactive Oxygen Species; Uropathogenic Escherichia coli | 2015 |
[PCR rationale for use of oral cephalosporins by oral surgery procedures].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Ceftibuten; Cephalosporins; DNA, Bacterial; Exudates and Transudates; Female; Humans; Male; Middle Aged; Oral Surgical Procedures; Pericoronitis; Polymerase Chain Reaction; Suppuration; Young Adult | 2014 |
Ceftibuten-containing agar plate for detecting group B streptococci with reduced penicillin susceptibility (PRGBS).
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Ceftibuten; Cephalosporins; Culture Media; Drug Resistance, Bacterial; Gentamicins; Humans; Japan; Nalidixic Acid; Sensitivity and Specificity; Streptococcal Infections; Streptococcus agalactiae | 2015 |
In Vitro Efficacy of Six Alternative Antibiotics against Multidrug Resistant Escherichia Coli and Klebsiella Pneumoniae from Urinary Tract Infections.
Topics: Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Genotype; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Penicillins; Singapore; Trimethoprim; Urinary Tract Infections | 2016 |
Tolerability of Cefazolin and Ceftibuten in Patients with IgE-Mediated Aminopenicillin Allergy.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftibuten; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Penicillins; Prospective Studies; Skin Tests | 2020 |